Anti-TNF-α (Adalimumab), humanized Antibody

Anti-TNF-α (Adalimumab), humanized Antibodyis available at Gentaur for Next week Delivery.

Description: Adalimumab (Humira), a human monoclonal antibody that specifically binds to tumor necrosis factor-alpha (TNF-a). Possessing a high specificity and affinity for TNFα adalimumab exerts its therapeutic effects by blocking the interaction of TNFα with the p55 and p75 receptors as well as inducing apoptosis of TNF-expressing mononuclear cells. Adalimumab can be used for the treatment of Rhcumatoid arthritis, Juvenilc Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn's Disease and Plaque Psoriasis.

Immunogen Sequence:Recombinant human TNF a

Target Alternative Name:Humira

Species Reactivities:Human

Tag Line:Monoclonal human IgG1 antibody against human TNF-α

Formulation:100 ug (2 mg/ml) of antibody in Phosphate buffered saline, pH 7.4.

Purification: human IgG1 was expressed in a human cell line. IgG was purified from CHO cell culture supernatant by protein A chromatography.

Application:Neutralization, ELISA

Positive Control:/

Application And Usages:Neutralization : 0.01-1 μg/ml; ELISA: 1μg/ml

Handling:The antibody solution should be gently mixed before use